Classes
DEA Class; Rx
Common Brand Names; Norpramin
- Antidepressants, TCAs
Description
Tricyclic antidepressant (TCA) of the dibenzazepine type; desipramine is the active metabolite of imipramine
FDA-approved for major depression in adults; evidence for off-label uses is low compared to established first-line treatments
Boxed warning for use in pediatric patients and young adults due to risk for suicidality
Indications
Indicated for the treatment of major depression.
Contraindications
Hypersensitivity
Acute recovery post-MI
Within 14 days of taking MAO inhibitor
Adverse Effects
Common
Fatigue
Lethargy
Sedation
Weakness
Constipation
Dry mouth
Blurred vision
Less Common
Agitation
Anxiety
Headache
Insomnia
Nausea
Vomiting
Sweating
Infrequent
ECG changes, orthostatic hypotension, tachycardia
Confusion, dizziness, paresthesia
Extrapyramidal symptoms
Rash
Elevated LFTs
Sexual dysfunction
Tinnitus
Rare
Seizure
Agranulocytosis
Eosinophilia
Leukopenia
Thrombocytopenia
SIADH
Warnings
Use caution in BPH and respiratory impairment
Risk of anticholinergic side effects
Clinical studies did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects; other reported clinical experience has not identified differences in responses between the elderly and younger patients
This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function; because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function
Use caution in patients with cardiovascular disease, because of possibility of conduction defects, arrhythmias, tachycardias, strokes, and acute myocardial infarction
Caution in patients who have a family history of sudden death, cardiac dysrhythmias, or cardiac conduction disturbances
Use caution in patients with a history of urinary retention or glaucoma, because of the anticholinergic properties of the drug
Caution in patients with thyroid disease or those taking thyroid medication, because of possibility of cardiovascular toxicity, including arrhythmias
Caution in patients with a history of seizure disorder, because this drug has been shown to lower seizure threshold; seizures precede cardiac dysrhythmias and death in some patients
The pupillary dilation that occurs following use of many antidepressant drugs may trigger an angle-closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy
The patient should be cautioned that this drug may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery
Pregnancy and Lactation
There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy
Safe use during lactation has not been established; therefore, if it is to be given to pregnant patients, nursing mothers, or women of childbearing potential, the possible benefits must be weighed against possible hazards to mother and child
Maximum Dosage
200 mg/day PO in outpatients; 300 mg/day PO for hospitalized patients.
150 mg/day PO.
150 mg/day PO.
>= 6 years: Safety and efficacy have not been established; however doses up to 5 mg/kg/day PO have been used for depression; use close monitoring for > 3 mg/kg/day PO.
< 6 years: Safety and efficacy have not been established.
How supplied
Desipramine hydrochloride
tablet
- 10mg
- 25mg
- 50mg
- 75mg
- 100mg
- 150mg